(Q28212716)

English

Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS

scientific article (publication date: April 2002)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Cytomegalovirus

0 references

cytomegalovirus retinitis

1 reference

based on heuristic

inferred from title

author name string

Vitravene Study Group

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

American Journal of Ophthalmology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

133

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

475-483

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Statistical methodology: IX. survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901326-0

7 January 2021

Identifiers

10.1016/S0002-9394(02)01326-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11931781%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28212716&oldid=1524607700"